Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/27383
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-06-24T11:32:07Z | - |
dc.date.available | 2022-06-24T11:32:07Z | - |
dc.date.issued | 2010-12 | - |
dc.identifier.citation | Şentürk, T. vd. (2010). "Serum choline levels in patients with stable angina and acute coronary syndromes: Relation to the severity of coronary artery disease". Coronary Artery Disease, 21(8), 466-471. | en_US |
dc.identifier.issn | 0954-6928 | - |
dc.identifier.uri | https://doi.org/10.1097/MCA.0b013e32833bdf39 | - |
dc.identifier.uri | https://journals.lww.com/coronary-artery/Fulltext/2010/12000/Serum_choline_levels_in_patients_with_stable.5.aspx | - |
dc.identifier.uri | http://hdl.handle.net/11452/27383 | - |
dc.description.abstract | Objective We sought to investigate whether serum choline levels are increased across the spectrum of coronary artery disease (CAD) manifestations and correlate with the severity of coronary stenosis. Methods A total of 36 patients with acute coronary syndrome (ACS) [22 patients with non-ST-segment elevation ACS and 14 patients with ST-segment elevation acute myocardial infarction (STEMI)], 22 patients with stable angina pectoris (SAP), and 18 controls were recruited for the study. In ACS patients, serum choline levels were measured on admission, and at 24 and 48 h thereafter, using high-performance liquid chromatography. The severity of CAD was assessed using the Gensini score. Results Serum choline levels on admission were significantly higher in the entire group of patients with ACS than in controls. The highest level of choline was observed in the STEMI group, followed by the SAP, and the non-ST-segment elevation ACS groups. Serum choline levels decreased gradually in patients with STEMI over the 48-h period. Serum choline levels on admission, and at 24 or 48 h thereafter, did not correlate with the presence of CAD neither in patients with ACS (P = 0.78, 0.98 and 0.98, respectively) nor in those with SAP (P = 0.92). Conclusion Our results suggest that serum choline levels are increased in ACS patients. However, there was no clear correlation between levels of choline and the severity and extent of CAD in this patient group. Coron Artery Dis 21:466-471 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Acute coronary syndrome | en_US |
dc.subject | Choline | en_US |
dc.subject | Coronary artery disease | en_US |
dc.subject | Stable angina pectoris | en_US |
dc.subject | Whole-blood choline | en_US |
dc.subject | Phospholipase-D | en_US |
dc.subject | Plaque vulnerability | en_US |
dc.subject | Atherosclerosis | en_US |
dc.subject | Macrophages | en_US |
dc.subject | Biomarkers | en_US |
dc.subject | Activation | en_US |
dc.subject | Mechanisms | en_US |
dc.subject | Ischemia | en_US |
dc.subject | Cardiovascular system & cardiology | en_US |
dc.subject.mesh | Acute coronary syndrome | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Angina pectoris | en_US |
dc.subject.mesh | Biological markers | en_US |
dc.subject.mesh | Chi-square distribution | en_US |
dc.subject.mesh | Choline | en_US |
dc.subject.mesh | Chromatography, high pressure liquid | en_US |
dc.subject.mesh | Coronary angiography | en_US |
dc.subject.mesh | Coronary stenosis | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Severity of illness index | en_US |
dc.subject.mesh | Time factors | en_US |
dc.subject.mesh | Troponin I | en_US |
dc.subject.mesh | Turkey | en_US |
dc.subject.mesh | Up-regulation | en_US |
dc.title | Serum choline levels in patients with stable angina and acute coronary syndromes: Relation to the severity of coronary artery disease | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000284150800005 | tr_TR |
dc.identifier.scopus | 2-s2.0-78649528602 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Farmakoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-8974-8837 | tr_TR |
dc.identifier.startpage | 466 | tr_TR |
dc.identifier.endpage | 471 | tr_TR |
dc.identifier.volume | 21 | tr_TR |
dc.identifier.issue | 8 | tr_TR |
dc.relation.journal | Coronary Artery Disease | en_US |
dc.contributor.buuauthor | Şentürk, Tunay | - |
dc.contributor.buuauthor | Tütüncü, Ahmet | - |
dc.contributor.buuauthor | Özdemir, Bülent | - |
dc.contributor.buuauthor | Özdabakoğlu, Osman | - |
dc.contributor.buuauthor | Aydın, Sami | - |
dc.contributor.buuauthor | Baran, İbrahim | - |
dc.contributor.buuauthor | Güllülü, Sümeyye | - |
dc.contributor.buuauthor | Savcı, Vahide | - |
dc.contributor.buuauthor | Aydınlar, Ali | - |
dc.contributor.researcherid | AAI-6632-2021 | tr_TR |
dc.contributor.researcherid | C-1517-2017 | tr_TR |
dc.identifier.pubmed | 20926949 | tr_TR |
dc.subject.wos | Cardiac & cardiovascular systems | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 8342098300 | tr_TR |
dc.contributor.scopusid | 7004229025 | tr_TR |
dc.contributor.scopusid | 7004168959 | tr_TR |
dc.contributor.scopusid | 25221805700 | tr_TR |
dc.contributor.scopusid | 7005387015 | tr_TR |
dc.contributor.scopusid | 35572557400 | tr_TR |
dc.contributor.scopusid | 57204660708 | tr_TR |
dc.contributor.scopusid | 6603687024 | tr_TR |
dc.contributor.scopusid | 6603131517 | tr_TR |
dc.subject.scopus | Choline; Dimethylglycine; Betaines | en_US |
dc.subject.emtree | Acetylsalicylic acid | en_US |
dc.subject.emtree | Beta adrenergic receptor blocking agent | en_US |
dc.subject.emtree | Calcium channel blocking agent | en_US |
dc.subject.emtree | Cholesterol | en_US |
dc.subject.emtree | Choline | en_US |
dc.subject.emtree | Creatine kinase MB | en_US |
dc.subject.emtree | Creatinine | en_US |
dc.subject.emtree | Glucose | en_US |
dc.subject.emtree | Hemoglobin | en_US |
dc.subject.emtree | High density lipoprotein cholesterol | en_US |
dc.subject.emtree | Low density lipoprotein cholesterol | en_US |
dc.subject.emtree | Nitrate | en_US |
dc.subject.emtree | Triacylglycerol | en_US |
dc.subject.emtree | Troponin I | en_US |
dc.subject.emtree | Acute coronary syndrome | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Case control study | en_US |
dc.subject.emtree | Cholesterol blood level | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Coronary artery disease | en_US |
dc.subject.emtree | Coronary artery obstruction | en_US |
dc.subject.emtree | Creatine kinase blood level | en_US |
dc.subject.emtree | Creatinine blood level | en_US |
dc.subject.emtree | Disease severity | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Glucose blood level | en_US |
dc.subject.emtree | Heart muscle injury | en_US |
dc.subject.emtree | Hemoglobin blood level | en_US |
dc.subject.emtree | High performance liquid chromatography | en_US |
dc.subject.emtree | Hospital admission | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Non ST segment elevation myocardial infarction | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Protein blood level | en_US |
dc.subject.emtree | Scoring system | en_US |
dc.subject.emtree | ST segment elevation myocardial infarction | en_US |
dc.subject.emtree | Stable angina pectoris | en_US |
dc.subject.emtree | Triacylglycerol blood level | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.